- Location
oral contraceptives
"-
That Long-Term Use of Oral Contraceptives Might Be a Potential Risk Factor for Glaucoma
Nov 27, 2013Women who took oral contraceptives for three or more years are twice as likely to suffer from glaucoma, a leading cause of blindness, a U.S. researcher says. Lead researcher Dr. Shan Lin, a professor of clinical ophthalmology at the ...
Tags: long-term, user, oral, contraceptive, glaucoma test
-
The US FDA Has Approved Teva Pharmaceutical Industries' New Drug Application
Apr 2, 2013The US FDA has approved Teva Pharmaceutical Industries' new drug application (NDA) for Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets as oral contraceptives. Quartette, designed as next generation of extended ...
Tags: Health, Medicine, oral contraceptives
-
FDA Has Issued Marketing Approval for Oral Contraceptive Medication
Jan 24, 2013The US FDA has issued marketing approval for Lupin Pharmaceuticals' Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.1mg / 0.02mg, the combined oral contraceptive. Levonorgestrel and Ethinyl Estradiol Tablets are the generic equivalent ...
Tags: FDA, Oral Contraceptive Medication, Lupin Pharmaceuticals
-
Famy Care Has Won Final FDA Approval
Jan 5, 2013Famy Care has won final FDA approval for abbreviated new drug application (ANDA) of Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15mg/0.03mg, generic equivalent to Teva Branded Pharmaceutical Products' Nordette 28 tablets. Mylan ...
Tags: Medicine
-
Lupin Pharmaceuticals Gained FDA Approval for Norgestimate and Ethinyl Estradiol Tablets
Dec 7, 2012Lupin Pharmaceuticals has gained FDA approval for its Norgestimate and Ethinyl Estradiol tablets, 0.18mg/0.025mg, 0.215mg/0.025mg, and 0.25mg/0.025mg. Norgestimate and Ethinyl Estradiol tablets are indicated for the prevention of ...
Tags: Lupin Pharmaceuticals, norgestimate and ethinyl estradiol tablets
-
Glenmark Generics Received Final FDA Approval for Abbreviated New Drug Application
Dec 7, 2012Glenmark Generics, a US subsidiary of Glenmark Pharmaceuticals, has received final FDA approval for its abbreviated new drug application for Norgestimate and Ethinyl Estradiol tablets USP 0.25mg/0.035mg. The product is the generic version ...
-
Bayer HealthCare Pharmaceuticals Has Updated The Labels
Dec 5, 2012Bayer HealthCare Pharmaceuticals has updated the labels for its drospirenone-containing combination oral contraceptives (COCs) in the US. The revised labels state that COCs containing drospirenone may be associated with a higher risk of ...
Tags: COCs containing drospirenone, VTE, venous thromboembolism
-
Glenmark Generics Has Announced a Consumer-Level Recall
Dec 3, 2012Glenmark Generics has announced a consumer-level recall of seven lots of Norgestimate and Ethinyl Estradiol tablets USP, 0.18mg/0.035mg, 0.215mg/0.035mg, 0.25mg/0.035mg, because of packaging error. Select blisters were rotated 180 ...
Tags: Recall, packaging error, medical product
-
Pfizer Has Voluntarily Recalled 14 Lots of Lo/Ovral-28 and 14 Lots of Norgestrel
Nov 30, 2012Pfizer has voluntarily recalled 14 lots of Lo/Ovral-28 and 14 lots of Norgestrel and Ethinyl Estradiol tablets in the US due to possibility of inexact tablet counts or out of sequence tablets. The products are indicated for the ...
Related Products
-
21+7 Oral Contraceptives: Levonorgestrel 0.15mg, Ethinylestradiol 0.03mg; Ferrous Fumarate 75mg Tablet
-
Levonorgestrel Tablet with GMP Emergency Contraceptive
-
Compound Fuma Ferrous Tablets Oral Contraceptives Tablets
-
Oral Contraceptives Tablets Support GMP
-
Reliable Oral Contraceptive Tablets for Effective Family Planning
-
Oral Contraceptives, 21+7, Medicine Factory
